Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Step by step instructions to Guarantee the Life span of Your Dental Inserts: Support and Care Guide- Winter solstice 2025 marks the shortest day of the year in the Northern Hemisphere today
- As juries turn against social media for harming kids, Big Tech's invincibility starts to show cracks
- Why screening for the deadliest cancer in the U.S. misses most cases
- Record-breaking 'space laser' erupts from merging galaxies 8 billion light-years away
- Birutė Galdikas: The last of the ‘angels’ in primatology’s most extraordinary chapter
- What is IDF's view on pontential long-term occupation of southern Lebanon?
- Winter virus season so far is not too bad, but doctors worry about suffering to come
- Hundreds are quarantined in South Carolina as measles spreads in 2 US outbreaks
